Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13.
Reglinski, M; Ercoli, G; Plumptre, C; KAY, E; Petersen, FC; Paton, JC; WREN, BW; Brown, JS;
2018
NPJ vaccines, (2018).3 1 10.1038/s41541-018-0090-4.
Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.
Hammitt, LL; Etyang, AO; Morpeth, SC; OJAL, J; Mutuku, A; Mturi, N; Moisi, JC; ADETIFA, IM; Karani, A; Akech, DO; OTIENDE, M; Bwanaali, T; Wafula, J; Mataza, C; Mumbo, E; Tabu, C; Knoll, MD; Bauni, E; Marsh, K; Williams, TN; Kamau, T; Sharif, SK; Levine, OS; SCOTT, JA G;
2018
Lancet, (2018).393 10186 10.1016/S0140-6736(18)33005-8.
Spatial Analyses of Oral Polio Vaccine Transmission in an Community Vaccinated With Inactivated Polio Vaccine.
JARVIS, CI; Altamirano, J; Sarnquist, C; EDMUNDS, WJ; Maldonado, Y;
2018
Clinical infectious diseases, (2018).67 suppl_ 10.1093/cid/ciy622.
Mathematical modelling of the epidemiological impact, cost-effectiveness and budget impact of novel tuberculosis vaccines on multidrug-resistant tuberculosis [Oral presentation].
WEERASURIYA, C; Harris, R; BOZZANI, F; MCQUAID, C; KNIGHT, G; SUMNER, T; Gomez, GB; WHITE, R;
2018
International Journal of Tuberculosis and Lung Disease, (2018).22 11
The impact of Measles-Rubella vaccination on the morbidity and mortality from Congenital Rubella Syndrome in 92 countries.
VYNNYCKY, E; Papadopoulos, T; Angelis, K;
2018
Human vaccines & immunotherapeutics, (2018).15 2 10.1080/21645515.2018.1532257.
Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
Pecenka, C; Debellut, F; Bar-Zeev, N; ANWARI, P; Nonvignon, J; Shamsuzzaman, M; CLARK, A;
2018
Vaccine, (2018).36 49 10.1016/j.vaccine.2018.10.068.
Benefits risk analysis of vaccination of pregnant women with rVSV-ZEBOV as part of expanded access programme.
EDMUNDS, J; JARVIS, C;
2018
(2018).
A process evaluation of how the routine vaccination programme is implemented at GP practices in England.
CROCKER-BUQUE, T; Edelstein, M; MOUNIER-JACK, S;
2018
Implementation science, (2018).13 1 10.1186/s13012-018-0824-8.
Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries.
GALLAGHER, KE; KELLY, H; Cocks, N; Dixon, S; MOUNIER-JACK, S; HOWARD, N; WATSON-JONES, D;
2018
Papillomavirus research (Amsterdam, Netherlands), (2018).6, 10.1016/j.pvr.2018.10.004.
Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation.
Kimaro Mlacha, SZ; Warira, A; Gatakaa, H; Goldblatt, D; SCOTT, JA G;
2018
Scientific reports, (2018).8 1 10.1038/s41598-018-33735-x.